584 filings
8-K
ENZ
Enzo Biochem, Inc.
13 Mar 24
Enzo Biochem Reports Second Quarter Fiscal 2024 Results and Provides Business Update
4:31pm
10-Q
2024 Q2
ENZ
Enzo Biochem, Inc.
Quarterly report
13 Mar 24
4:25pm
8-K
ENZ
Enzo Biochem, Inc.
27 Feb 24
Departure of Directors or Certain Officers
4:05pm
8-K
ENZ
Enzo Biochem, Inc.
1 Feb 24
Enzo Biochem Reports Results of its Annual Meeting of Shareholders and Officer Appointments
8:33am
DEFR14A
ENZ
Enzo Biochem, Inc.
21 Dec 23
Revised proxy
4:48pm
ARS
jd04q xfafmsqj
21 Dec 23
Annual report to shareholders
4:15pm
NT 10-K
y0pb9wi9ffc73
30 Oct 23
Notice of late annual filing
6:19pm
8-K
u4zp6v
30 Oct 23
Departure of Directors or Certain Officers
4:50pm
8-K
yd5tw
6 Sep 23
Enzo Biochem Announces Departure of Hamid Erfanian and Appointment of Kara Cannon as Interim CEO
6:12pm
8-K/A
k55to fvq
28 Jul 23
Financial Statements and Exhibits
5:19pm
8-K
cpgbk1r7cxtl45z4
24 Jul 23
Enzo Biochem Completes Sale of Clinical Laboratory to Labcorp
4:32pm
EFFECT
h88 xxmnr
19 Jul 23
Notice of effectiveness
12:15am
424B3
asr62 3y2bs8hmzmt3
18 Jul 23
Prospectus supplement
9:42pm
CORRESP
w7mwxcd
18 Jul 23
Correspondence with SEC
12:00am
CORRESP
imr9lh
18 Jul 23
Correspondence with SEC
12:00am
8-K
5vwf2b8ubr4fw4o 53n4
17 Jul 23
Other Events
1:38pm